Cargando…
Exploring Amodiaquine’s Repurposing Potential in Breast Cancer Treatment—Assessment of In-Vitro Efficacy & Mechanism of Action
Due to the heterogeneity of breast cancer, current available treatment options are moderately effective at best. Hence, it is highly recommended to comprehend different subtypes, understand pathogenic mechanisms involved, and develop treatment modalities. The repurposing of an old FDA approved anti-...
Autores principales: | Parvathaneni, Vineela, Chilamakuri, Rameswari, Kulkarni, Nishant S., Baig, Nabeela F., Agarwal, Saurabh, Gupta, Vivek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569809/ https://www.ncbi.nlm.nih.gov/pubmed/36232751 http://dx.doi.org/10.3390/ijms231911455 |
Ejemplares similares
-
Repurposing Quinacrine for Treatment of Malignant Mesothelioma: In-Vitro Therapeutic and Mechanistic Evaluation
por: Kulkarni, Nishant S., et al.
Publicado: (2020) -
Development and Characterization of Folic Acid-Conjugated Amodiaquine-Loaded Nanoparticles–Efficacy in Cancer Treatment
por: Parvathaneni, Vineela, et al.
Publicado: (2023) -
Utilizing drug repurposing against COVID-19 – Efficacy, limitations, and challenges
por: Parvathaneni, Vineela, et al.
Publicado: (2020) -
COVID-19: Characteristics and Therapeutics
por: Chilamakuri, Rameswari, et al.
Publicado: (2021) -
Dual Targeting of PI3K and HDAC by CUDC-907 Inhibits Pediatric Neuroblastoma Growth
por: Chilamakuri, Rameswari, et al.
Publicado: (2022)